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Abstract
Background: This study describes a bioinformatics approach designed to identify Plasmodium vivax proteins potentially
involved in reticulocyte invasion. Specifically, different protein training sets were built and tuned based on different
biological parameters, such as experimental evidence of secretion and/or involvement in invasion-related processes. A
profile-based sequence method supported by hidden Markov models (HMMs) was then used to build classifiers to search
for biologically-related proteins. The transcriptional profile of the P. vivax intra-erythrocyte developmental cycle was then
screened using these classifiers.
Results: A bioinformatics methodology for identifying potentially secreted P. vivax proteins was designed using sequence
redundancy reduction and probabilistic profiles. This methodology led to identifying a set of 45 proteins that are potentially
secreted during the P. vivax intra-erythrocyte development cycle and could be involved in cell invasion. Thirteen of the 45
proteins have already been described as vaccine candidates; there is experimental evidence of protein expression for 7 of
the 32 remaining ones, while no previous studies of expression, function or immunology have been carried out for the
additional 25.
Conclusions: The results support the idea that probabilistic techniques like profile HMMs improve similarity searches. Also,
different adjustments such as sequence redundancy reduction using Pisces or Cd-Hit allowed data clustering based on
rational reproducible measurements. This kind of approach for selecting proteins with specific functions is highly important
for supporting large-scale analyses that could aid in the identification of genes encoding potential new target antigens for
vaccine development and drug design. The present study has led to targeting 32 proteins for further testing regarding their
ability to induce protective immune responses against P. vivax malaria.
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Introduction
Human malaria is caused by five parasite species from the genus
Plasmodium, of which Plasmodium falciparum has a preferential
distribution in African countries and is particularly important,
since it produces most of the fatal cases. The second species in
clinical importance for humans is Plasmodium vivax (predominantly
distributed throughout Asia and America). P. vivax does not cause
such an imminent life-threatening condition as that caused by P.
falciparum; however, it imposes an important social and economic
toll on the world’s poorest countries, as reflected in the large
number of disability adjusted life years (DALYs) associated with its
incidence [1]. Furthermore, several aspects still hamper the total
eradication of this disease, which include (1) the gradual
emergence of antimalarial drug resistance among parasite strains,
as well as (2) insecticide-resistant populations of the malaria
mosquito vector, and (3) the lack of an effective vaccine [2].
Progress in P. vivax research has been notably delayed by
contrast with P. falciparum, partly due to the difficulty of
establishing a long-term in vitro culture of this species given that
it is restricted to invading human reticulocytes which only account
for ,1–2% of circulating red blood cells. This difficulty has been
reflected in the delayed release of its genome sequence [3], the
transcriptional profile of its intra-erythrocyte developmental cycle
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the release of the same studies in P. falciparum. In silico approaches
have emerged from such experimental limitations, thereby
promoting the development of an automatic analysis of the P.
vivax transcriptome aimed at identifying parasite genes that have
dominant transcription during schizont stages, mainly 30–
48 hours post-infection, based on the rationale that they could
be encoding proteins involved in P. vivax invasion of human
reticulocytes [4].
Hidden Markov models (HMMs) are among the most effective
and efficient approaches for analyzing large sets of biological data
[6–8]. These models have been applied over the last 20 years in
sequence analysis, gene finding and protein family characteriza-
tion [9]. Chen et al., designed a predictor for secreted proteins
using HMM-based methods in 2003 to identify signal peptides and
transmembrane proteins [10]; in 2009 Tinhosolo et al., identified
carotenoid genes in P. falciparum by comparing biosynthesis-related
genes against a local database of P. falciparum genes using BLAST
and HMM [11]. In the same year, Gaskell et al.., identified
secreted enzymes in Toxoplasma gondii using SHARKhunt which
used profile HMM based on the PRIAM polypeptide profile
library to search for a set of genomic DNA sequences potentially
encoding such proteins [12]. In 2010, Arena et al., identified 16
new genes encoding trypsin proteases in 8 Apicomplexan genomes
[13]. Ghouila et al., constructed a system for identifying protein
domains based on comparing HMM and Pfam profiles so that a
Pfam family was represented by a multiple sequence alignment
and a profile HMM [14].
More specifically, different HMM-based approaches have been
proposed for the search, identification and characterization of new
vaccine candidate proteins in the Plasmodium genus. A method
for detecting new protein domains in P. falciparum using co-
occurrence was proposed by Terrapon et al., in 2009 [15]. This
method has been claimed to improve the sensitivity of Pfam
domain detection. More recently, Bischoff and Vaquero, in 2010
[16], reported a set of proteins potentially involved in the
transcriptional machinery of the Plasmodium genus, based on in
silico reports and databases. Particularly, a directory of factors
associated with Plasmodium transcription was built by scanning
the Plasmodium genome using profile HMMs. It should be
stressed that HMMER software was used for the searches related
to both methods [17].
One of the most used profile HMM-based tools is HMMER
v3.0 which is a new generation of sequence homology search
software that is used for querying sequence databases for protein
homologues and performing protein alignment. Compared to
BLAST, FASTA and other sequence alignment and database
search tools based on classical scoring methodology, HMMER has
been shown to be significantly more accurate and better at
detecting remote homologues because of the strength of its
underlying mathematical models. In the past, this strength came at
significant computational expense, but in the new HMMER3
project, HMMER is now essentially as fast as BLAST [18].
Several adjustments to the input data are required as part of
the process for obtaining the different probabilistic profile
HMMs taking into account that, if there is a high degree of
similarity among the biological sequences, any analysis could be
biased due to redundancy. Different efficient algorithms allow a
set of sequences to be constructed with a degree of similarity
below a given parameter. Cd-hit uses an algorithm based on
short word filtering (i.e. dipeptides, tripeptides, etc.) to determine
protein similarity taking into account the minimum number of
identical short substrings [19]. On the other hand, PISCES [20]
uses PSI-BLAST and an inclusion/exclusion label process that is
based on the size of the parameter that determines the similarity
threshold.
This study describes an approach to the large-scale identifica-
tion and selection of proteins playing an active role in P. vivax
invasion of human reticulocytes. It is based on identifying secreted
and/or invasion-related proteins using sequence redundancy
reduction and profile HMMs to analyze genome-annotated genes
with significantly high levels of transcription toward the end of the
intra-erythrocyte cycle. The preference for this transcriptional
stage was based on the premise that gene expression is timely
regulated and therefore biological functions can be assigned to a
particular instant of the parasite’s developmental cycle inside the
infected red blood cell [4]. The selected candidates were further
analyzed; this included reviewing published experimental evidence
of role during invasion and/or immunological assays leading to
their classification as vaccine candidates and experimental
confirmation of protein presence. Supporting information based
on the prediction of subcellular localization and signal sequence,
number of transmembrane regions, identification of glycosylpho-
sphatidylinositol (GPI)–anchor sites and functional domains
related to invasion, and prediction of adhesion activity was also
assessed. The objective was to define robust selection criteria based
on a bioinformatics strategy to find P. vivax proteins likely to be
interesting vaccine candidates.
Results
The results were based on the 3 phases proposed in the
methodology (Figure 1). The first one consisted of constructing
36 profile HMMs and a target data set of 582 P. vivax open
reading frames (ORFs) with predominant transcription toward
the end of the intra-erythrocyte cycle. In the second phase
(identification), the 36 profile HMMs were used for exploring
the target data set, leading to the discovery of 46 P. vivax ORFs
scanned by the profile HMMs. Forty-five of them encoded
potentially secreted and/or invasion-related proteins, while the
remaining one belonged to the negative set. It is worth noting
that ORFs were included irrespective of whether they were
identified once or several times. The resulting ORFs/proteins
were screened in the third phase according to a literature review
of published evidence regarding their secretion or previous use
as vaccine candidates.
Phase 1: Constructing protein profile HMMs (1a) and
target data set (1b)
Nine protein sequence data sets were also constructed to create
the protein profile HMMs. It should be highlighted that data sets
had different construction criteria, were processed by 2 different
redundancy reduction algorithms and that cut-off values were
established at 2 different identity percentages, leading to 36
profiles in total being obtained (Table 1).
Table 2 shows the ORFs/proteins identified by the 36 profile
HMMs that were constructed from 9 Plasmodium protein data
sets (Table S1); 8 of them were considered as secreted and some
have been reported as being involved in invasion, while the
remaining set contained the non-secreted proteins.
The target data set was constructed from proteins encoded in
the P. vivax genome showing a peak transcription at the end of the
intra-erythrocyte development cycle and which could therefore
have potential roles in the invasion of reticulocytes [4].
Consequently, this data set only included genes exhibiting a
Cy5/Cy3 expression ratio larger than 1.5 at the end of the intra-
erythrocyte cycle (31–48 hours post-invasion) (Table S2).
P. vivax Vaccine Candidate Selection Using HMMs
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identification step
The analysis shows that, even though some sequences were
shared between profile HMMs, the different modifications applied
to the 9 protein data sets led to different results being obtained in
all cases, except for the negative profile, in which all the 4 profile
HMM modifications pointed to the same protein (PVX_090110),
as will be further explained below (Table 2).
A close analysis of Table 2 indicates that the 36 profile HMMs
allowed tracking new candidate ORFs/proteins. Interestingly, 34
out of the 46 ORFs/proteins identified by the different profile
HMMs were identified by more than one profile HMM, while the
remaining 12 were identified only once. The most frequently
identified ORFs/proteins were: PVX_117880 (27 times),
PVX_092975 (18 times) and PVX_002510 (17 times). On the
other hand, PVX_080305, PVX_112665, PVX_092995,
PVX_081810, PVX_101505, PVX_094425, PVX_086850,
PVX_081845, PVX_097710, PVX_123550, PVX_109280, and
PVX_118525 were identified only once. The profile HMMs
labeled as ‘‘42, Pisces 90% identity’’, ‘‘67, Cd-hit 30% identity’’,
‘‘88, Cd-hit 30% identity’’ and ‘‘118, Pisces 30% identity’’ in
Table 2 were those that identified the largest number of ORFs/
proteins (12 in total).
Regarding the negative set, containing non-secreted reported
ORFs/proteins used as a probe to validate the consistency of the
results, only PVX_090110 was identified as a non-secreted protein
out of the initial set of target proteins. This was the only case in
which all profile HMMs identified the same protein.
Table S3 shows the protein domain families indexed in PFAM
(version 25.0), which were reported by the hmmscan algorithm as
being related to each built data set’s protein sequences.
Specifically, 310 domains were scanned in the PFAM database.
The AMA-1 Apical membrane antigen 1, DUF605 Vta 1 like and
MSP7_C MSP7-like protein C-terminal domains were the most
Figure 1. Methodology for identifying Plasmodium vivax proteins having a potential role in invasion using sequence redundancy
reduction and profile hidden Markov models.
doi:10.1371/journal.pone.0025189.g001
Table 1. Plasmodium protein data sets used for profile HMMs construction.
Protein existence** Organism
# of proteins Type Query Prot/Trans Predicted Putative Homology P. falciparum P. vivax P. berghei P. yoelii
129* Neg Database 34 1 0 94 75 10 12 12
133 Pos Database 21 81 22 9 79 28 15 11
118 Pos Lit/DB 20 69 22 7 66 28 14 10
110 Pos Database 21 81 0 1 71 21 8 10
88 Pos Lit/DB 20 69 0 0 54 20 6 8
68 Pos Lit/DB 0 68 0 0 48 11 4 5
67 Pos Literature 6 48 8 5 67 0 0 0
42 Pos Lit/DB 20 0 22 0 12 16 10 4
20 Pos Lit/DB 20 0 0 0 6 9 2 3
*The remaining protein sequences correspond to P. chabaudi (10), P. knowlesi (8), P. gallinaceum (1) and P. malariae (1).
**Level of evidence that supports the existence of the protein concerned. ‘‘Prot/Trans’’ indicates that there is clear experimental evidence for the existence of the
protein or that expression data indicate the existence of a transcript. ‘‘Homology’’ indicates that the existence of a protein is probable because orthologs exist in closely-
related species. ‘‘Predicted’’ is used for entries without evidence at protein, transcript, or homology levels. ‘Putative’ indicates putative proteins having predicted
existence.
doi:10.1371/journal.pone.0025189.t001
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Hit 90%) profile scanned the highest number of domains (171
domains in total) (Table S3).
It should be stressed that the negative profile HMM scanned
164 domains that were not recognized by the positive profiles; 139
domains were thus recognized by the positive profiles but not by
the negative ones. There were only 7 domains, which were
recognized by both positive and negative profile HMMs (Table
S3).
Phase 3: Selection step
The 46 proteins identified in the target data set (45 positive and
1 negative) were compared against those reported in the literature
and analyzed in terms of several structural features such as the
presence of putative classical and non-classical signal sequences,
the number of transmembrane helices, the presence of GPI-
anchor sites, as well as the presence of protein domains relevant for
invasion of erythrocytes and able to mediate cell adhesion
(Table 3). The final categorization included 13 proteins which
had already been classified as vaccine candidates according to
previous studies; 9 of these have been tested for their antigenicity
[21–25], two have been assayed for their protection-inducing
ability [5,21,26,27] and strong reticulocyte-binding ability has
been described for the remaining two [28,29]. Experimental
evidence of protein expression has been published for 7 additional
ORFs; however, no immunological or functional assays testing
their potential role as vaccine candidates have been reported yet
[5,30–32]. Interestingly, 25 ORFs for which there is no additional
experimental evidence, apart from their transcriptional profile,
were also identified. This last group plus that containing the seven
proteins for which immunological studies are lacking thus became
interesting protein candidates to be further tested in vaccination
assays (giving a total of 32 selected). The last protein out of the 46
classified was the negative one (Table 3).
Importantly, 18 out of the 32 selected proteins were predicted as
being secreted via the classical pathway to the extracellular
medium and having a signal peptide, while three additional ones’
secretion seems to occur via the non-classical pathway, according
to at least four prediction tools. Predictors yielded contradictory
results for the 11 remaining proteins.
Discussion
Adjusting and modifying the algorithm parameters shifted the
probability of the appearance of biological variables represented in
the sequences, thereby broadening the identification of molecules
likely to be far-relatives within the target protein data set. It should
be noted that, although the data used for constructing the protein
profile HMMs were similar (Table 1), the results obtained differed
for all profiles so constructed (Tables 2 and 3).
Probabilistically, when a data set is analyzed by means of a
redundancy adjustment algorithm, then it would be assumed that,
depending on the extent of decreased identity percentage values,
there should be more diversity among results. Different identity
percentage parameters were thus explored, seeking to favor
sequences which, while being different, did share some degree of
similarity. The methodology followed in protein set definition and
adjustment was thus designed considering that profiles adjusted to
30% identity would be more diverse in terms of the variables
included in them. However, since the data sets for constructing the
profile HMMs were so limited according to the selection criteria, it
was difficult to establish such relationship.
As for the set of the 45 proteins identified, the presence of
several of them was somehow expected considering that they
belong to families that have already been characterized as good
malaria antigen candidates; specifically, 6 proteins belonged to the
serine repeat antigen family (SERA) which is considered a vaccine
candidate antigen for P. falciparum malaria due to the immuno-
genicity conferred in rats by one of them when expressed as a
recombinant protein [33]. It is worth noting that all 6 proteins
identified as being SERA were P. falciparum SERA1, SERA2,
SERA3, SERA4, SERA5, SERA6, SERA7 and SERA9 orthologs
(Table S4). This group also included two ORFs identified as being
rhoptry-associated proteins (RAP1 and RAP2). Some of the
previously identified and characterized rhoptry proteins have been
found to be actively involved in red blood cell invasion as they are
able to bind to red blood cells or since monoclonal or polyclonal
antibodies raised against them have inhibited in vitro invasion of
target cells [32,34]. An additional rhoptry protein (RON2) [30]
expressed in the rhoptry necks was also identified. Previous studies
have shown that the RON2 ortholog in P. falciparum is essential for
parasite invasion due to its interaction with AMA-1 [35].
The profile HMMs also identified reticulocyte binding proteins
(RBP1 and RBP2) which are directly associated with P. vivax
merozoites’ preference for invading human reticulocytes [28]; 9
MSP3 and 1 MSP7 (merozoite surface proteins 3 and 7,
respectively) were similarly identified. MSPs are among the best
candidate antigens for inclusion in an antimalarial vaccine, mainly
because their surface localization facilitates their initial attachment
to the red blood cell and involvement in subsequent invasion [36].
Moreover, this localization leaves them accessible to interact with
host antibodies.
Regarding the protein identified as negative, it should be noted
that it was only identified by the four probabilistic profiles
constructed from the data set of 129 proteins, using the redundancy
reduction algorithms at 30% and 90% identity (Table 2).
Of the 32 ‘‘selected’’ proteins (Table 3), 26 have orthologs in
other species from the Plasmodium genus but the present analysis
focused on 21 of them having orthologs in P. falciparum. The list of
orthologous proteins can be found in Table S4.
Although tools predicting protein localization within a broader
range of cellular organelles in eukaryotes are currently available, it
has been particularly difficult to define which motifs or domains
are exclusively associated with proteins located in apical organelles
[37]. The only consensus regarding signals targeting proteins to
cell surface or to apical compartments so far consists of the
presence of a classical signal sequence or, eventually, the presence
of some secondary targeting signals [38,39]. This led us to perform
an additional analysis of the set of 45 identified proteins to define
priorities in identifying new antigens which are potentially
involved in P. vivax invasion of reticulocytes. It was thus
ascertained whether proteins had a classical signal peptide
sequence, as well as the presence and number of transmembrane
regions, GPI-anchor sites and domains known to be involved in
host-cell invasion, and their ability to mediate cell adhesion.
It has been observed that parasite antigens involved in host-cell
invasion that are targeted to membrane or apical organelles are
stabilized within such organelles via transmembrane helices or, if
such regions are lacking, then by their non-covalent association
with other anchored-proteins [39].
It is clear that an important number of P. falciparum cell surface-
associated proteins are attached to the plasma membrane via GPI
anchors [40]. Is also well known that some of these proteins play
an active role in host-cell invasion through their incorporation into
lipid rafts [41], also being recognized by neutralizing antibodies
induced during natural malarial infection in people living in
endemic areas [42]. Based on these data, various GPI-anchored
proteins, such as MSP1 and MSP2, have been or are currently
P. vivax Vaccine Candidate Selection Using HMMs
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species [43]. Given the importance of proteins containing GPI-
anchor sites, understood as a post-translational modification, a
GPI-anchored prediction was thus run on the set of 45 proteins
identified using the FragAnchor tool [44]. Such analysis predicted
a highly probable (HP) GPI-anchor attachment site in 2 of these
proteins and 3 had a potentially false positive GPI-anchor site
(Table 3).
Despite the difficulty in determining consensus domains and
motifs of apical organelle proteins in members of the phylum
Apicomplexa, the 45 proteins selected in the computational
protein identification were screened against the CODD database
[15]. Among the domains used as search query, only those
potentially involved in host-cell invasion by mediating adhesion to
receptors on the target cell surface or actively involved in
shedding-off other parasite proteins were included. This search
for P. vivax proteins containing one or more of these domains was
carried out using PlasmoDB v6.1 based on a list of accession codes
for the domains reported in PFAM [45] and InterPro [46]
(Table 3).
Another alternative was to check which selected proteins were
predicted to act as adhesins. The MAAP [47] tool was thus used
which was designed on the sequence composition of a group of
proteins from the genus Plasmodium, experimental evidence
having shown them to be directly involved in adhesion to host cells
(Table 3).
It should be noted that even though the performance of the
approach chosen here depended on the current status of parasite
genome annotation, the exploratory methodology focused on
identifying true positive values and therefore sought to optimize
search precision rate. The results are thus not to be measured by
the number of proteins so identified but rather by the method’s
reliability in confirming that such identified proteins are actually
true positives. In other words, the fraction of true vaccine
candidates among those that the algorithm identified as belonging
to the candidates subset had to be close to one.
The information made available through the publication of the
genome sequences of several parasites and their hosts, as well as of
malaria vector mosquitoes, together with analyses focused on the
detection and quantification of parasite gene transcription and
protein expression, is now allowing novel strategies to be
postulated and better approaches to be adopted for designing
more effective vaccines, drugs, diagnostic methods and treatments
[48]. This study constitutes an exploratory and rational approach
toward the identification of P. vivax proteins playing a potential
role in invasion of human reticulocytes based on the search for far-
homologues by applying algorithmic techniques for adjusting
sequences in regards to redundancy, construct profiles based on
HMMs and analyzing protein features such as amino acid
composition and secretion pathways.
Materials and Methods
The bioinformatics approach proposed in this paper explored a
methodology for identifying P. vivax proteins that could be involved
in parasite invasion of reticulocytes, therefore making them
interesting vaccine candidates. The methodology was based
primarily on the use of techniques for reducing sequence
redundancy and constructing HMM-based profiles. The main
purpose of the methodology was the construction of various
probabilistic profiles to search for biologically-related proteins in the
P. vivax intra-erythrocyte transcriptome. The probabilistic profiles
were built using different data sets with sequences from the
Plasmodiumgenus(9setsintotal(TableS1),eachwith4profiles,for
a total of 36 profile HMMs) generated by varying protein feature
parameters, and which were adjusted using 2 different methods to
reduce redundancies. Proteins identified as possible candidates were
furtheranalyzed according to theirsequence and additional features
to select the most likely vaccine candidates (Figure 1).
The approach followed in this study can be divided into 3 main
phases (Figure 1). The objective of the first two phases was to
identify proteins potentially involved in P. vivax invasion of
reticulocytes. These stages involved generating suitable data sets
(phase 1a), eliminating protein sequence redundancy (phase 1a),
generating protein alignments and obtaining probabilistic profiles
based on HMMs (phase 1a), generating the 582 P. vivax target data
set (phase 1b) (Table S2) and scanning the target data set with the
profile HMMs (phase 2). The protein set obtained after these
stages included previously reported proteins that had been
described as participating in P. vivax invasion but, more
interestingly, it also contained proteins that have not been
previously implicated in cell invasion.
The third phase, denoted as the selection step, consisted of
debugging the data set obtained in the previous stages to select the
most likely vaccine candidates. This included reviewing scientific
literature in the search for previous experimental evidence
regarding vaccine candidates or expressed proteins. In addition,
the identified proteins were analyzed using different computational
classifiers to detect cellular secretion, signal peptides, transmem-
brane regions, GPI-anchor regions, invasion-related domains and
adhesion-like proteins. The orthologs for all the proteins identified
are reported in Table S4. A detailed description of each step
followed in these 3 phases is given below.
Phase 1: Constructing protein profile HMMs and the
target data set
Constructing the protein sequences. Positive and negative
sets of proteins were created based on a literature review and
search in biological databases (Table 1). In the case of the positive
data set, 8 subsets of non-exclusive proteins were formed to model
the possible values for a protein’s attributes and the organism to
which it belonged. Specifically, the attribute ‘‘Protein existence’’
from the SwissProt database was modeled by generating data sets
representing each possible value for that attribute (‘‘predicted’’ and
‘‘putative or hypothetical’’). Similarly, the organism to which the
protein belonged was modeled by including the four species of
Plasmodium considered here. The negative set consisted of proteins
having an annotation of being localized in cytoplasm, nucleus,
mitochondria, or retained in the endoplasmic reticulum, whereas
the positive set clustered proteins targeted at P. falciparum, P. vivax,
P. berghei and P. yoelii cell surface, rhoptries or micronemes.
Table S1 shows the 9 different data sets created for the
exploration. It should be noted that there was no exclusive set of
proteins for each data set, but rather proteins were shared between
more than one set.
The set construction generated sets having divergent features
(Table 1). Specifically, the number of sequences ranged between
133 sequences (Set 2) and 20 sequences (Set 9). Some of the sets
resulted from combining searches in databases and literature
reviews (Sets 3 and 5 to 9) while other sets were built strictly on
query results from databases (Sets 1, 2 and 4). The parameter of
‘‘existence’’ diverged between the sets, allowing for some of them
to contain proteins for all possible values (Sets 2, 3 and 7) whereas
others were restricted to proteins combining two of these
annotations (Sets of 4, 5 and 8) and others were restricted to
proteins with one particular type of annotation (Set 6 and 9).
Regarding distribution in the organism of origin, some sets were
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tended to cluster proteins from P. vivax (Sets 8 and 9).
It is worth noting special features for certain data sets. For
example, Set 7 clustered 67 P. falciparum proteins reported as being
involved in invasion and with annotations of function, subcellular
localization and time during the cycle in which they are
transcribed [49]. Similarly, all proteins present in the data sets
were compared with the target set and were extracted before
constructing the profiles. This step was carried out to avoid biasing
profile construction by favoring sequences repeated between a
specific profile and the target set.
An essential premise was that the divergence among the data sets
reported in Table 1 allowed generating different probabilistic
profiles, therefore leading to different search approaches within the
target data set. The negative set was used to validate the robustness
of the results obtained in the exploration of the target data set.
Reducing redundancy. The task was performed by applying
the Cd-hit [19] and PISCES [20] algorithms to each of the 9
protein profile data sets (defined in the previous subsection),
according to 2 identity parameters (30% and 90% identity). This
reduction of redundancy resulted in a total of 36 subsets.
Constructing protein profile HMMs data sets. This stage
consisted of obtaining protein alignments. Sequence alignments
for the 36 subsets (defined in the previous subsection) were
obtained using the ClustalW2 suite [50].
A profile HMMs comparison between the different data sets and
the PFAM 25.0 database was also performed. Specifically, the
‘hmmscan’ algorithm in the HMMER v3.0 suite [18] was the choice
selected for a protein sequence vs profile-HMM database query.
Table S3 shows the domains reported as being related to data set
protein sequences. The profile HMMs are publicly available in
http://www.biolisi.unal.edu.co/publications/supplementary-files/p_
vivax/.
Target data set. This set was constructed on P. vivax gene
mRNA abundance levels during each time interval during the
intra-erythrocyte cycle, expressed in terms of the degree of RNA
hybridization in the microarray compared to hybridization in
the RNA reference pool assembled from the RNA samples from
all time points for the 3 studied isolates [4]. Of the total of 5,335
genes analyzed in the 3 clinical isolates, only those genes
showing a Cy5/Cy3 ratio higher than 1.5 in the TP7–9 time
interval (corresponding to 31–48 hours of intra-erythrocyte
cycle), but not in any of the previous time intervals (TP1–6),
were selected. This selection considered genes transcribed in at
least one P. vivax isolate to discard genes that did not have a
single maximum transcription peak at the end of the intra-
erythrocyte cycle.
It should be noted that genes having larger transcription peaks at
any previous time (0–30 hours) were not taken into account. The
transcription criteria ‘‘at the end of the intra-erythrocyte cycle’’ was
chosen due to previous evidence showing that most P. falciparum
genes encoding proteins having important roles in erythrocyte
invasion have a peak transcription during this lapse of time, which
agrees with merozoite maturation and the development of apical
organelles (rhoptries, micronemes and dense granules) [51]. This
resulted in a target data set of 582 transcribed genes (Table S2).
All amino acid sequences used in this study, either identified
previously or as a result of P. falciparum and P. vivax genome
annotation were downloaded from the PlasmoDB database [52],
with their corresponding accession codes.
Phase 2: Protein profiles against target data set and
protein identification
The probabilistic profiles were obtained and used as query for
searching in the target protein data set using HMMER v 3.0
software [18]. The results for this phase are reported in Table 2.
Phase 3: Protein selection
The protein identification described in the previous section
defined a set of 46 candidates (Table 3). This set of proteins was
further characterized according to structural features regarding
secretion and the transcriptional profile reported in PlasmoDB.
These results were then contrasted with previous literature reports
to classify proteins already being considered as vaccine candidates
and those that were not. As a result of this analysis, the identified
proteins were grouped into two categories: ‘‘vaccine candidates’’
and ‘‘selected’’. The respective sub-categories can be found in
Table 3.
The P. vivax gene homologues located in syntenic regions
were identified in the annotated P. falciparum genome by
screening the PlasmoDB [52] and the OrthoMCL–DB [48]
databases (Table S4). The subcellular localization of the pool of
proteins selected based on the abovementioned criteria was also
predicted using tools based on Support Vector Machine (SVM)
systems and/or homology-based analyses. The ESLpred2 tool
[53] hosted at http://www.imtech.res.in/raghava/eslpred2/
and BaCelLo [54] available at http://gpcr.biocomp.unibo.it/
bacello/were used, selecting the animal kingdom-specific
predictor in both cases.
The next step was to screen proteins for the presence of a signal
peptide using various tools for predicting the secretion pathway in
eukaryotic proteins. SignalP 3.0 [55] http://www.cbs.dtu.dk/
services/SignalP/was used for classical secretion as it combines
neural networks (NN) and hidden Markov models (HMM), as well
as PolyPhobius [56] http://phobius.sbc.su.se/poly.html, a tool
that allows determining transmembrane topology performing an
HMM algorithm using homology information. Secretion via non-
classical pathways was predicted using SecretomeP 2.0 [57]
available at http://www.cbs.dtu.dk/services/SecretomeP/.
Transmembrane helices and GPI anchors were also reported as
part of the analysis. PolyPhobius and TMHMM v 2.0 [58] http://
www.cbs.dtu.dk/services/TMHMM/were used for predicting the
presence and number of transmembrane regions in the pool of
chosen peptide sequences. The latter tool is based on the use of an
HMM; however, unlike PolyPhobius, TMHMM sometimes
incorrectly classifies the signal peptide as a transmembrane region.
Those regions predicted as transmembrane helices but showing at
least 50% similarity with one or both of the signal peptide
predictions mentioned above were thus discarded. All proteins
were analyzed for the presence of GPI-anchor sites using
FragAnchor (http://navet.ics.hawaii.edu/,fraganchor/NNHMM/
NNHMM.html) [44] which is based on the tandem use of NN and
HMM predictors.
P. vivax proteins having a potential adhesive function, being
understood as a protein’s ability to adhere to another protein or
molecule on red blood cell surface, were identified using the
Malarial Adhesins and Adhesin–like proteins (MAAP) predictor
[59] available at http://maap.igib.res.in/, which is a non-
homology-based approach that implements the compositional
characteristics of amino acid dipeptides and multiplet frequencies
with an SVM-based classification system.
P. vivax Vaccine Candidate Selection Using HMMs
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